Herbaridine BCAS# 1151511-05-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
| Cas No. | 1151511-05-5 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Yellow powder |
| Formula | C17H20O6 | M.Wt | 320.34 |
| Type of Compound | Other Quinones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | C1=C2C(=C(C=C1OC)OC)C([C@@H]3[C@@H](C2=O)C[C@@](C)(OC3)OC)=O | ||
| Standard InChIKey | XWDPPCCHTXTSRZ-NVGCLXPQSA-N | ||
| Standard InChI | InChI=1S/C17H20O6/c1-17(22-4)7-11-12(8-23-17)16(19)14-10(15(11)18)5-9(20-2)6-13(14)21-3/h5-6,11-12H,7-8H2,1-4H3/t11-,12-,17+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Herbaridine B Dilution Calculator
Herbaridine B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1217 mL | 15.6084 mL | 31.2168 mL | 62.4337 mL | 78.0421 mL |
| 5 mM | 0.6243 mL | 3.1217 mL | 6.2434 mL | 12.4867 mL | 15.6084 mL |
| 10 mM | 0.3122 mL | 1.5608 mL | 3.1217 mL | 6.2434 mL | 7.8042 mL |
| 50 mM | 0.0624 mL | 0.3122 mL | 0.6243 mL | 1.2487 mL | 1.5608 mL |
| 100 mM | 0.0312 mL | 0.1561 mL | 0.3122 mL | 0.6243 mL | 0.7804 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 4-Chloropinselin
Catalog No.:BCN9668
CAS No.:104022-83-5
- Euglobal Ia2
Catalog No.:BCN9667
CAS No.:77794-63-9
- Phomaligol A
Catalog No.:BCN9666
CAS No.:152204-32-5
- Polyhydroxybutyrate
Catalog No.:BCN9665
CAS No.:26744-04-7
- (+)-Hannokinol
Catalog No.:BCN9664
CAS No.:408324-76-5
- (±)-Magnolin
Catalog No.:BCN9663
CAS No.:1275595-33-9
- (±)-Lariciresinol
Catalog No.:BCN9662
CAS No.:105367-81-5
- Trolline
Catalog No.:BCN9661
CAS No.:1021950-79-7
- Plucheoside B aglycone
Catalog No.:BCN9660
CAS No.:393862-19-6
- benzyl hydrogen (3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-imino-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate
Catalog No.:BCN9659
CAS No.:889852-02-2
- Dexamethasone 21-phosphate disodium salt
Catalog No.:BCN9658
CAS No.:2392-39-4
- Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate
Catalog No.:BCN9657
CAS No.:429659-01-8
- 18-Hydroxytritriacontan-16-one
Catalog No.:BCN9670
CAS No.:97191-42-9
- (2Z,6Z,10E,14E,18E)-Farnesylfarnesol
Catalog No.:BCN9671
CAS No.:90695-03-7
- 5-O-Ethylcleroindicin D
Catalog No.:BCN9672
CAS No.:488138-32-5
- 3-Hydroxychimaphilin
Catalog No.:BCN9673
CAS No.:33253-99-5
- Cerebroside D
Catalog No.:BCN9674
CAS No.:113773-89-0
- Dehydroacerogenin C
Catalog No.:BCN9675
CAS No.:152041-27-5
- 8-Methoxyfissistigine C
Catalog No.:BCN9676
CAS No.:20824-18-4
- 10-Epiteuclatriol
Catalog No.:BCN9677
CAS No.:151563-36-9
- Jaslanceoside B
Catalog No.:BCN9678
CAS No.:188300-82-5
- Spirotryprostatin A
Catalog No.:BCN9679
CAS No.:182234-25-9
- Muricarpone B
Catalog No.:BCN9680
CAS No.:886226-15-9
- Integracin B
Catalog No.:BCN9681
CAS No.:224186-05-4
Anteaglonialides A-F and Palmarumycins CE(1)-CE(3) from Anteaglonium sp. FL0768, a Fungal Endophyte of the Spikemoss Selaginella arenicola.[Pubmed:26539727]
J Nat Prod. 2015 Nov 25;78(11):2738-47.
Anteaglonialides A-F (1-6), bearing a spiro[6-(tetrahydro-7-furanyl)cyclohexane-1,2'-naphtho[1,8-de][1,3]-dioxin]-10-on e skeleton, three new spirobisnaphthalenes, palmarumycins CE1-CE3 (7-9), nine known palmarumycin analogues, palmarumycins CP5 (10), CP4a (11), CP3 (12), CP17 (13), CP2 (14), and CP1 (15), CJ-12,371 (16), 4-O-methyl CJ-12,371 (17), and CP4 (18), together with a possible artifact, 4a(5)-anhydropalmarumycin CE2 (8a), and four known metabolites, O-methylherbarin (19), herbarin (20), Herbaridine B (21), and hyalopyrone (22), were encountered in a cytotoxic extract of a potato dextrose agar culture of Anteaglonium sp. FL0768, an endophytic fungus of the sand spikemoss, Selaginella arenicola. The planar structures and relative configurations of the new metabolites 1-9 were elucidated by analysis of extensive spectroscopic data, and the absolute configuration of 1 was determined by the modified Mosher's ester method. Application of the modified Mosher's ester method combined with the NOESY data resulted in revision of the absolute configuration previously proposed for 10. Co-occurrence of 1-6 and 7-18 in this fungus led to the proposal that the anteagloniolides may be biogenetically derived from palmarumycins. Among the metabolites encountered, anteaglonialide F (6) and known palmarumycins CP3 (12) and CP1 (15) exhibited strong cytotoxic activity against the human Ewing's sarcoma cell line CHP-100, with IC50 values of 1.4, 0.5, and 1.6 muM, respectively.
